NEW YORK (GenomeWeb) – Myriad Genetics this week denied allegations of patent infringement levied against it in a US District Court by LabCorp subsidiary Esoterix Genetic Laboratories (EGL), arguing that its myRisk Hereditary Cancer panel and related services do not make use of the digital PCR technology covered in the intellectual property at the center of the dispute.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The apple has traveled westward and eastward along the Silk Road, according to a new genetic analysis.

In Nature this week: GWAS data used to reposition drugs for psychiatric use, and more.

Genetic disease risk information doesn't always spur people to make healthy lifestyle changes, according to the Associated Press.

A University of California, San Diego-led team has used liquid biopsies to uncover possible treatments for patients with cancers of unknown primary.